Pinnacle Associates LTD Compugen LTD Transaction History

Pinnacle Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$1.57 - $3.33 $31,400 - $66,600	-20,000 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$2.76 - $4.64 $5,520 - $9,280	-2,000 Reduced 9.09%	20,000 $64,000
Q4 2021 Feb 02, 2022	BUY	$4.09 - $7.16 $26,994 - $47,256	6,600 Added 42.86%	22,000 $95,000
Q3 2021 Oct 19, 2021	BUY	$5.8 - $8.02 $6,380 - $8,822	1,100 Added 7.69%	15,400 $92,000
Q2 2021 Aug 02, 2021	BUY	$6.87 - $9.16 $3,435 - $4,580	500 Added 3.62%	14,300 $118,000
Q1 2021 May 12, 2021	BUY	$7.67 - $13.77 $105,846 - $190,026	13,800 New	13,800 $119,000

16.3M

28.7K

48.3K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $127M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.